## AXON: Axon Enterprise, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.2% below STRENGTH zone (3.0-6.0%); PEG 2.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($508.35)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Axon Plunges 31.1% in 6 Months: Should You Hold or Fold the Stock?**
- Source: Finviz | 20251204T170826 | Neutral | Relevance: 100%
- Axon Enterprise, Inc. (AXON) has seen its stock price drop by 31.1% in the past six months, underperforming its industry and the S&P 500. Despite long-term growth prospects driven by its Connected Devices and Software & Services segments, the company faces near-term challenges including escalating costs, rising debt, and a high valuation. While existing shareholders are advised to hold, new investors should wait for a better entry point due to these headwinds.

**2. Axon Plunges 31.1% in 6 Months: Should You Hold or Fold the Stock?**
- Source: TradingView | 20251204T150933 | Somewhat-Bearish | Relevance: 100%
- Axon Enterprise (AXON) has seen its stock price drop 31.1% in the last six months, underperforming its industry and the S&P 500, despite a strong two-year return. While the company faces near-term challenges like rising costs, increased debt, and a high valuation, its Connected Devices and Software & Services segments show bright long-term growth prospects. Analysts suggest current shareholders hold, but new investors should await a better entry point due to its premium valuation.

**3. Axon Enterprise, Inc. (AXON): A Bull Case Theory**
- Source: Insider Monkey | 20251204T124400 | Somewhat-Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Axon Enterprise, Inc. (AXON) from Rebound Capital, highlighting the company's near-monopoly in non-lethal weapons and expansion into integrated hardware and software solutions. Despite a recent 35% stock drawdown due to profitability pressures from tariffs, increased R&D, and stretched valuation, the company has strong long-term potential fueled by new product rollouts, international expansion, and continued demand for less-lethal policing solutions. The thesis suggests catalysts like new offerings and international growth could lead to a rebound, though it notes AXON's premium valuation and margin pressures.

**4. Axon Enterprise, Inc. (AXON): A Bull Case Theory**
- Source: Finviz | 20251204T124400 | Somewhat-Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Axon Enterprise, Inc. (AXON), highlighting its strong long-term performance driven by its Taser products and integrated ecosystem of hardware and high-margin software. Despite a recent stock drawdown due to profitability pressures, the company has several catalysts for rebound, including new product rollouts, international expansion, and industry tailwinds. Analysts are generally bullish on AXON's future potential.

**5. Can Axon Maintain EBITDA Margin Momentum Amid Cost Pressures?**
- Source: TradingView | 20251202T172110 | Somewhat-Bullish | Relevance: 100%
- Axon Enterprise, Inc. (AXON) demonstrated strong financial performance in the first nine months of 2025, with a significant increase in adjusted EBITDA and margin expansion driven by product sales and cost management. The company is optimistic about its full-year 2025 EBITDA outlook, despite facing challenges in price performance and valuation compared to its peers. While Axon focuses on improving its margins, competitors like Kratos Defense & Security Solutions, Inc. and Teledyne Technologies Incorporated are struggling with cost pressures and declining margins.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | RBC Capital | $860 | $0 | 0% |
| 2025-11-06 | Barclays | $702 | $861 | -18% |
| 2025-11-05 | UBS | $610 | $840 | -27% |
| 2025-11-05 | Goldman Sachs | $800 | $940 | -15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | RBC Capital | init | Outperform |
| 2025-11-06 | Barclays | main | Overweight |
| 2025-11-05 | UBS | main | Neutral |
| 2025-11-05 | Goldman Sachs | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.00M) |
| Sells | 19 ($26.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+4.2%)
- Blackrock Inc.: 10.4% (+8.3%)
- State Street Corpora: 4.3% (+6.4%)
- FMR, LLC: 3.8% (+2.1%)
- Geode Capital Manage: 2.8% (+5.7%)

### Key Risks

1. Heavy insider selling: $26M sold (19 transactions in 90 days).
2. Valuation risk: PEG 2.9x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 18.6% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +2.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.86 signals overvaluation risk, limited margin of safety. Forward P/E 73.0x stretched relative to 19% growth. Balance sheet: strong liquidity (3.1x). Revenue growth strong at 25% YoY. Analyst sentiment negative (4 target cuts vs 0 raises). Insider selling cluster ($26.0M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.4B |
| Beta | 1.40 |
| 52W Range | $469.24 - $885.92 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.86 |
| Forward P/E | 73.0 |
| Current P/E | 87.2 |
| YoY Growth | 19.4% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -1.4% to 1.2% (+2.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.8pp (needs >3.0% for momentum thesis). MRS_5 at 1.3% confirms short-term momentum alignment. Below SMA200 (0.81x), long-term trend not supportive. MACD histogram positive (6.61), confirming momentum. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.22% (CS: 66) | Neutral |
| RSI_14 | 37.6 | Neutral |
| MACD Histogram | 6.61 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 0.852x | Below |
| vs SMA200 | 0.814x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $550.61
- **Stop Loss:** $508.35 (7.7% risk)
- **Target:** $592.87 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 23
- **Position Value:** $12,664.03
- **Portfolio %:** 12.66%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-24 (Est: $1.60)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.54 | $1.17 | -24.1% |
| 2025Q2 | $1.46 | $2.12 | +45.0% |
| 2025Q1 | $1.28 | $1.41 | +10.2% |
| 2024Q4 | $1.40 | $2.08 | +48.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*